Removal of two sentinel nodes accurately stages the axilla in breast cancer

British Journal of Surgery

Volumn 90, Issue 11, 2003, Pages 1349-1353

  Kennedy, R J ^a,c   Kollias, J ^a   Gill, P G ^a   Bochner, M ^a   Coventry, B J ^a   Farshid, G ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0242721770     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4298     Document Type: Article

References (25)

1. Krontiras H, Morrow M. Options for management of the axillary lymph nodes in breast cancer. Breast 2001; 10(Suppl 3): 62-68.
2. Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer. ALMANAC Trial. World J Surg 2001; 25: 819-822.
3. Gill PG. SNAC Trial design and current status. Aust N Z J Surg 2002; 72: A5.
4. Steele RJC, Forrest APM, Gibson T, Stuart HJ, Chetty U. The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 1985; 72: 368-369.
5. Dixon JM, Dillon P, Anderson TJ, Chetty U. Axillary node sampling in breast cancer: an assessment of its efficacy. Breast 1998; 7: 206-208.
6. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88: 608-614.
7. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bendoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997; 349: 1864-1867.
8. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-398.
9. Giuliano AE, Jones RC, Brennan M, Statmen R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345-2350.
10. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer - a multicentre validation study. N Engl J Med 1998; 339: 941-946.
11. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 226: 645-653.
12. Hill ADK, Tran KN, Akhurst T, Yeung H, Yeh SDJ, Rosen PP et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528-535.
13. Nieweg OE, Rutgers EJT, Jansen L, Valdes Olmos RA, Peterse JL, Hoefhagel KA et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001; 25: 780-788.
14. Mann GB, Buchanan M, Collins PJ, Lichtenstein M. High incidence of micrometastases in breast cancer sentinel nodes. Aust N Z J Surg 2000; 70: 786-790.
15. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne D. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
16. Rampaul RS, Miremadi A, Pinder SE, Lee A, Ellis IO. Pathological validation and significance of micrometastases in sentinel nodes in primary breast cancer. Breast Cancer Res 2001; 3: 113-116.
17. Kollias J, Gill PG, Chatterton BE, Hall VE, Bochner MA, Coventry BJ et al. Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer. Med J Aust 1999; 171: 461-465.
18. Uren RF, Thompson JF, Howman-Giles RB. Lymphatic Drainage of the Skin and Breast: Locating the Sentinel Nodes. Harwood Academic Publishers: Amsterdam, 1999.
19. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T et al. Distribution of axillary node metastases by level of invasion. An analysis of 559 cases. Cancer 1986; 59: 682-687.
20. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 1990; 16: 127-133.
21. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
22. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC et al. Pathologic features associated with non-sentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-581.
23. Quan ML, McCready D, Temple WJ, McKinnon JG. Biology of lymphatic metastases in breast cancer: lessons learned from sentinel node biopsy. Ann Surg Oncol 2002; 9: 467-471.
24. Schrenk P, Rehberger W, Shamiyeh A, Wayand W. Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node? J Surg Oncol 2002; 80: 130-136.
25. Nano MT, Kollias J, Farshid G, Gill PG, Bochner M. Clinical impact of false negative sentinel node biopsy in primary breast cancer. Br J Surg 2002; 89: 1430-1434.